Cite
HARVARD Citation
Algotar, A. et al. (2013). Phase 3 clinical trial investigating the effect of selenium supplementation in men at high‐risk for prostate cancer. Prostate. 73 (3), pp. 328-335. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Algotar, A. et al. (2013). Phase 3 clinical trial investigating the effect of selenium supplementation in men at high‐risk for prostate cancer. Prostate. 73 (3), pp. 328-335. [Online].